Anti-NAPG monoclonal antibody

Pre-made anti-NAPG monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NAPG/NAPG products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2623-Ab-1/ GM-Tg-hg-IP2623-Ab-2Anti-Human NAPG monoclonal antibodyHuman
GM-Tg-rg-IP2623-Ab-1/ GM-Tg-rg-IP2623-Ab-2Anti-Rat NAPG monoclonal antibodyRat
GM-Tg-mg-IP2623-Ab-1/ GM-Tg-mg-IP2623-Ab-2Anti-Mouse NAPG monoclonal antibodyMouse
GM-Tg-cynog-IP2623-Ab-1/ GM-Tg-cynog-IP2623-Ab-2Anti-Cynomolgus/ Rhesus macaque NAPG monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2623-Ab-1/ GM-Tg-felg-IP2623-Ab-2Anti-Feline NAPG monoclonal antibodyFeline
GM-Tg-cang-IP2623-Ab-1/ GM-Tg-cang-IP2623-Ab-2Anti-Canine NAPG monoclonal antibodyCanine
GM-Tg-bovg-IP2623-Ab-1/ GM-Tg-bovg-IP2623-Ab-2Anti-Bovine NAPG monoclonal antibodyBovine
GM-Tg-equg-IP2623-Ab-1/ GM-Tg-equg-IP2623-Ab-2Anti-Equine NAPG monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2623-Ab-1/ GM-Tg-hg-IP2623-Ab-2; GM-Tg-rg-IP2623-Ab-1/ GM-Tg-rg-IP2623-Ab-2;
GM-Tg-mg-IP2623-Ab-1/ GM-Tg-mg-IP2623-Ab-2; GM-Tg-cynog-IP2623-Ab-1/ GM-Tg-cynog-IP2623-Ab-2;
GM-Tg-felg-IP2623-Ab-1/ GM-Tg-felg-IP2623-Ab-2; GM-Tg-cang-IP2623-Ab-1/ GM-Tg-cang-IP2623-Ab-2;
GM-Tg-bovg-IP2623-Ab-1/ GM-Tg-bovg-IP2623-Ab-2; GM-Tg-equg-IP2623-Ab-1/ GM-Tg-equg-IP2623-Ab-2
Products NameAnti-NAPG monoclonal antibody
Formatmab
Target NameNAPG
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NAPG monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2623-Ag-1Recombinant multi-species SNAG/ NAPG/ GAMMASNAP protein
    ORF Viral VectorvGMLP002784human NAPG Lentivirus particle
    ORF Viral VectorpGMLP002784human NAPG Lentivirus plasmid
    ORF Viral VectorpGMLPm001176mouse Napg Lentivirus plasmid
    ORF Viral VectorvGMLPm001176mouse Napg Lentivirus particle


    Target information

    Target IDGM-IP2623
    Target NameNAPG
    Gene ID8774,108123,307382,704546,608647,101099595,509041,100050057
    Gene Symbol and Synonyms2400003O04Rik,GAMMASNAP,NAPG,SNARE
    Uniprot AccessionQ99747,P81127
    Uniprot Entry NameSNAG_HUMAN,SNAG_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000134265
    Target ClassificationN/A

    The target: NAPG, gene name: NAPG, also named as GAMMASNAP. This gene encodes soluble NSF attachment protein gamma. The soluble NSF attachment proteins (SNAPs) enable N-ethyl-maleimide-sensitive fusion protein (NSF) to bind to target membranes. NSF and SNAPs appear to be general components of the intracellular membrane fusion apparatus, and their action at specific sites of fusion must be controlled by SNAP receptors particular to the membranes being fused. The product of this gene mediates platelet exocytosis and controls the membrane fusion events of this process.[provided by RefSeq, Dec 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.